Gulam Hekimoglu

Gulam Hekimoglu

Auto-generated profile, based on publicly available information

Gulam Hekimoglu

Department of Histology and Embryology, Hamidiye International School of Medicine University of Health Sciences Istanbul Turkey

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 November 2022 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
TSTansel Sapmaz
Tansel Sapmaz
KSKubra Sevgin
Kubra Sevgin
STSude Topkaraoglu
Sude Topkaraoglu
Muhammetnur TekayevMuhammetnur Tekayev
Muhammetnur Tekayev
FGFatma Gumuskaya
Fatma Gumuskaya
OIOktay Irkorucu
Oktay Irkorucu

3 March 2023 in The European Research Journal
Verified
Journal Article
Open access
PDF file
GHGulam Heki̇moğlu
Gulam Heki̇moğlu
SKSumeyye Koc
Sumeyye Koc
ADAli İmran Daştan
Ali İmran Daştan
KSKubra Sevgin
Kubra Sevgin
Muhammetnur TekayevMuhammetnur Tekayev
Muhammetnur Tekayev
EKEbru Kale
Ebru Kale
Objectives: Apigenin and parthenolide as natural products have potent antioxidant and anti-inflammatory outcomes that could make them a perfect option for endometriosis therapy. This study aimed to determine the effects of apigenin and parthenolide on created endometrial implants in a rat model of endometriosis. Methods: Thirty-nine mature, female Sprague-Dawley rats were assigned randomly to six experimental groups four weeks after endometriosis induction. Group 1 (n = 5): Control (CTRL) that opened and closed the abdomen; Group 2 (n = 6): Peritoneal and ovarian endometriosis (POE) + drug-free; Group 3 (n = 7): POE+ Apigenin (APG) (50 mg/kg); Group 4 (n = 7): POE+ Parthenolide (PTL) (10 mg/kg); Group 5 (n = 7): POE+ Apigenin (APG) (50 mg/kg) + Parthenolide (PTL) (10 mg/kg); Group 6 (n = 7): POE+ DMSO. An endometriosis model was created, and histopathological analysis and biochemical evaluation were performed. Serum and peritoneal levels of pro-and-anti-inflammatory cytokine, and oxidative stress of implant tissue were measured. Results: Serum IL-37 levels decreased significantly in the APG-treated group compared to the drug-free group (p = 0.016). The peritoneum and ovary endometriosis histopathologic scores were significantly lower in APG-treated (p = 0.001) and PTL-treated (p = 0.001) groups in comparison to the drug-free group. The oxidative stress index (OSI) values were increased statistically significantly in ovary endometriosis tissue in the drug-free group, (p = 0.001). However, compared to the drug-free group, OSI values decreased statistically significantly in the APG-treated group (p = 0.003).Conclusions: The application of apigenin caused a decrease in oxidative stress and an improvement in histopathological grade. Apigenin may be a novel therapeutic agent for the treatment of endometriosis.

17 August 2023 in Pathology International
Verified
Journal Article
Closed access
AWAini Wulamujiang
Aini Wulamujiang
SOSeyma Ozkanli
Seyma Ozkanli
ECEnder Coskunpinar
Ender Coskunpinar
HCHalime Canbaz
Halime Canbaz
GYGamze Yesilay*
Gamze Yesilay*
KSKubra Sevgin
Kubra Sevgin

15 May 2023 in Medical Records
Verified
Journal Article
Open access
PDF file
WAWulamujiang Ai̇nİ
Wulamujiang Ai̇nİ
CÖCandan Yilmaz Özdoğan
Candan Yilmaz Özdoğan
GMGamze Kara Mağden
Gamze Kara Mağden
EDEmek Doğer
Emek Doğer
VKVildan Küçükoğlu
Vildan Küçükoğlu
HKHalime Kenar
Halime Kenar
Aim: Gestational diabetes mellitus (GDM) is associated with an increased risk of fetal and maternal complications, such astype 2 DM (diabetes mellitus) and cardiovascular disease (CVD). This study aimed to predict the potential for future vascular complications in mothers with GDM by evaluating oxidative stress, endothelial NO synthase (eNOS) expression, and vascular smooth muscle cell (VSMC) proliferation in the umbilical vessels of mothers with GDM. Material and Methods: Subjects were divided into two groups: the normoglycemic control (NGC) group (n = 10) and the GDM group (n = 12). Expression of eNOS and production of reactive oxygen species (ROS) in human umbilical vein endothelial cells (HUVECs) were determined. The mitochondrial mass of HUVECs was evaluated by spectrofluorometry. VSMC proliferation was ascertained in vitro with an EdU cell proliferation assay. Advanced glycation end products (AGEs) accumulation was measured by ELISA and assessed by immunohistochemical staining Results: VSMC proliferation, eNOS expression, and ROS production in HUVECs were significantly increased, and greater immunohistochemical staining to AGEs was observed in endothelium in GDM. Conclusion: Increased oxidative stress, which elevates eNOS expression and VSMC proliferation in the umbilical vessels of mothers with GDM, may be a sign that mothers have a high potential for developing diabetes or cardiovascular disease in the future.